Search

Search Results
Results 5951 - 5960 of 8239 for Skin Cancer
  • Nexium Hp7
    Drug - 7 Jan 2025
    Consumer Medicine Information (CMI) about Nexium Hp7 intended for persons living in Australia.
  • Abraxane
    Drug - 10 Dec 2024
    Consumer Medicine Information (CMI) about Abraxane intended for persons living in Australia.
  • Bondronat
    Drug - 4 Dec 2024
    Consumer Medicine Information (CMI) about Bondronat intended for persons living in Australia.
  • Micardis Plus
    Drug - 21 Nov 2024
    Consumer Medicine Information (CMI) about Micardis Plus intended for persons living in Australia.
  • Study reveals racial bias in postsurgical analgesia
    News - 21 Oct 2024
    While recovering from major surgery, Black patients may be less likely to receive certain multimodal analgesia options and more likely to receive oral opioids than white patients, according to...
  • Newly identified 'headspin hole' affects breakdancers’ scalp health
    News - 12 Oct 2024
    Breakdancers may be at risk of developing a condition caused by repeatedly doing a cardinal move of their practice and performance - the headspin - warn doctors in the journal BMJ Case Reports.
  • Ofev
    Drug - 13 Sep 2024
    Consumer Medicine Information (CMI) about Ofev intended for persons living in Australia.
  • Calquence tablets
    Drug - 3 Sep 2024
    Consumer Medicine Information (CMI) about Calquence tablets intended for persons living in Australia.
  • Calquence
    Drug - 3 Sep 2024
    Consumer Medicine Information (CMI) about Calquence intended for persons living in Australia.
  • Femara
    Drug - 19 Aug 2024
    Consumer Medicine Information (CMI) about Femara intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback